By Paul McClure A clinical trial has shown that a rheumatoid arthritis drug can preserve the pancreas’ ability to produce insulin in newly diagnosed type 1 diabetics Depositphotos A world-first clinical trial has found that baricitinib, a drug commonly prescribed for rheumatoid arthritis, preserved the pancreatic cells’ ability to produce their own insulin and slowed the...
